gdrx-20260616
0001809519FALSE2701 Olympic BoulevardSanta MonicaCalifornia00018095192026-06-162026-06-16
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 8-K
________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 16, 2026
________________________________________
GoodRx Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
________________________________________
Delaware
001-39549
47-5104396
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2701 Olympic Boulevard
Santa Monica, California
90404
(Address of Principal Executive
Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (855) 268-2822
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per
share
GDRX
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act.
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 16, 2026, GoodRx Holdings, Inc. (the “Company”) held its Annual Meeting of Stockholders. Holders of the
Company’s Class A common stock were entitled to one vote per share held as of the close of business on April 20, 2026 (the
“Record Date”) and holders of the Company’s Class B common stock were entitled to ten votes per share held as of the
Record Date. A total of 89,932,951 shares of the Company’s Class A common stock and 233,964,187 shares of the
Company’s Class B common stock were present in person or represented by proxy at the meeting, representing
approximately 99.4% of the combined voting power of the Company’s Class A and Class B common stock as of the Record
Date. The following are the final voting results for the proposals considered and voted upon at the meeting, each of which
were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April
29, 2026.
Item 1 — Election of three Class III directors for a term of office expiring on the date of the Annual Meeting of
Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified or until their
respective earlier death, resignation or removal.
Votes FOR
Votes WITHHELD
Broker Non-Votes
Wendy Barnes
2,379,952,868
10,078,860
39,543,093
Ronald E. Bruehlman
2,380,863,641
9,168,087
39,543,093
Gregory Mondre
2,382,474,121
7,557,607
39,543,093
Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2026.
Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
2,429,055,999
335,716
183,106
0
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive
officers.
Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
2,363,913,370
23,702,520
2,415,838
39,543,093
Based on the foregoing votes, the Company’s stockholders (i) elected Wendy Barnes, Ronald E. Bruehlman and
Gregory Mondre as Class III directors; (ii) ratified the appointment of KPMG LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2026; and (iii) approved, on an advisory (non-binding) basis,
the compensation of the Company’s named executive officers.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
GOODRX HOLDINGS, INC.
Date:
June 18, 2026
By:
/s/ Christopher McGinnis
Name: Christopher McGinnis
Title: Chief Financial Officer & Treasurer